Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023
Clay Hair Conditioner
"We'll need to do more research to see if semaglutide can, rarely, cause severe hypoglycemia or if people are starving themselves
This effect persists even in patients who achieve modest weight loss, suggesting a metabolic benefit independent of body mass changes alone
Commercial Codes: Use 45378 (Diagnostic Colonoscopy) with Modifier 33
CareCredit offers flexible financing options that allow you to pay over time, including promotional financing for 6, 12, or 18 months on qualifying purchases of $200 or more made with your CareCredit credit card.* * Subject to credit approval